首页> 外文会议>International Conference on Informatics, Management, and Technology in Healthcare >Access of Stroke Patients’ to Optimal Healthcare Technology in Greece: Messages to Policy Makers
【24h】

Access of Stroke Patients’ to Optimal Healthcare Technology in Greece: Messages to Policy Makers

机译:卒中患者在希腊最佳医疗保健技术的进入:对政策制定者的信息

获取原文

摘要

The aim of this study was to evaluate accessibility of stroke patients to optimal healthcare technology in Greece. Methods: The study population consisted of 313 first ever stroke patients derived from the “Stroke Units Necessity for Patients, SUN4P” registry. Descriptive statistics were used, to present patients’ characteristics and resources utilization Results: The vast majority of patients (91.7%) conducted a CT scan during the acute phase (within the first 24hours). Almost, (65%) were admitted to wards of Internal Medicine Departments, whereas only 21% of patients were admitted to a Stroke Unit. Of note, a total of 6.9% of ischemic stroke patients received intravenous thrombolytic therapy with recombinant tissue plasminogen activator (rtPA). Conclusions: Preliminary results from SUN4P underline the urgent necessity for the re-organization of acute stroke care in Greece, as rates of admissions to stroke units and rtPA treatment during the acute phase are currently below optimal.
机译:本研究的目的是评估中风患者的可及性在希腊最佳医疗保健技术。方法:研究人群由313名卒中患者组成,源自“患者患者,SUN4P”登记处的“卒中单位必需品”。使用描述性统计数据,呈现患者的特征和资源利用率结果:绝大多数患者(91.7%)在急性期(前24小时内)进行CT扫描。几乎(65%)被录取为内科部门的病房,而只有21%的患者被录取到行程单位。值得注意的是,6.9%的缺血性卒中患者接受了重组组织纤溶酶原激活剂(RTPA)的静脉溶栓治疗。结论:Sun4P的初步结果强调了希腊急性中风护理重新组织急性中风护理的迫切性,因为急性期急性期和RTPA治疗的入学率目前低于最佳。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号